CTC
ABMD

Central Trust Company’s Abiomed Inc ABMD Stock Holding History

Central Trust Company’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-35
Closed -$11K – 1311
2021
Q2 		$11K Sell
35
-1,029
-97% -$316K ﹤0.01% 1012
2021
Q1 		$339K Buy
1,064
+638
+150% +$204K 0.01% 434
2020
Q4 		$138K Buy
+426
New +$118K 0.01% 533
2020
Q3 		– Sell
-34
Closed -$8K – 1121
2020
Q2 		$8K Hold
34
– – ﹤0.01% 870
2020
Q1 		$5K Sell
34
-820
-96% -$136K ﹤0.01% 994
2019
Q4 		$146K Sell
854
-26
-3% -$4.82K 0.01% 511
2019
Q3 		$157K Sell
880
-12
-1% -$2.59K 0.01% 473
2019
Q2 		$237K Sell
892
-1,051
-54% -$279K 0.01% 429
2019
Q1 		$555K Sell
1,943
-108
-5% -$35.9K 0.03% 303
2018
Q4 		$667K Sell
2,051
-1
-0% -$347 0.04% 267
2018
Q3 		$923K Sell
2,052
-1,373
-40% -$541K 0.05% 248
2018
Q2 		$1.4M Buy
3,425
+898
+36% +$325K 0.09% 195
2018
Q1 		$735K Sell
2,527
-288
-10% -$73K 0.05% 276
2017
Q4 		$528K Sell
2,815
-220
-7% -$41.1K 0.03% 335
2017
Q3 		$512K Buy
3,035
+180
+6% +$27.2K 0.03% 320
2017
Q2 		$409K Buy
+2,855
New +$384K 0.03% 342

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Central Trust Company's ABMD Position: Q3 2021 in Review

Central Trust Company sold out of Abiomed Inc (ABMD) in Q3 2021, closing a stake of 35 shares — an estimated $11K sold.

Central Trust Company first reported a position in ABMD in Q2 2017 and held it in 16 quarters. The position peaked at $1.4M in Q2 2018. 498 funds tracked by Wall St. Rank hold ABMD as of Q3 2021.

  • Central Trust Company reported no remaining Abiomed Inc position as of Q3 2021 after selling out during the quarter.
  • Central Trust Company sold 35 Abiomed Inc shares in Q3 2021, an estimated $11K.
  • Central Trust Company first reported a position in Abiomed Inc in Q2 2017 and held it in 16 quarters.
  • Central Trust Company's Abiomed Inc position peaked at $1.4M in Q2 2018.
  • 498 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2021.

Based on Central Trust Company's 13F filing for Q3 2021, filed 19 Oct 2021.